LMP/BARF1/EBNA1-specific cytotoxic T lymphocytes

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LMP/BARF1/EBNA1-specific cytotoxic T lymphocytes, covering 2025-02-24 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) [Phase 1]

See pricing